An engineered microvirin variant with identical structural domains potently inhibits human immunodeficiency virus and hepatitis C virus cellular entry

M Shahid, A Qadir, J Yang, I Ahmad, H Zahid, S Mirza… - Viruses, 2020 - mdpi.com
Microvirin (MVN) is one of the human immunodeficiency virus (HIV-1) entry inhibitor lectins,
which consists of two structural domains sharing 35% sequence identity and contrary to …

Solution structure of the monovalent lectin microvirin in complex with Manα (1–2) Man provides a basis for anti-HIV activity with low toxicity

S Shahzad-ul-Hussan, E Gustchina, R Ghirlando… - Journal of Biological …, 2011 - ASBMB
Lectins that bind surface envelope glycoprotein gp120 of HIV with high avidity can potently
inhibit viral entry. Yet properties such as multivalency that facilitate strong interactions can …

Constitutively active MAVS inhibits HIV-1 replication via type I interferon secretion and induction of HIV-1 restriction factors

S Gupta, JM Termini, B Issac, E Guirado, GW Stone - PLoS One, 2016 - journals.plos.org
Type I interferon is known to inhibit HIV-1 replication through the induction of interferon
stimulated genes (ISG), including a number of HIV-1 restriction factors. To better understand …

Microvirin, a novel α (1, 2)-mannose-specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher …

D Huskens, G Férir, K Vermeire, JC Kehr… - Journal of Biological …, 2010 - ASBMB
Microvirin (MVN), a recently isolated lectin from the cyanobacterium Microcystis aeruginosa
PCC7806, shares 33% identity with the potent anti-human immunodeficiency virus (HIV) …

Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses

X Sun, H Zhang, S Xu, L Shi, J Dong, D Gao, Y Chen… - Virology Journal, 2017 - Springer
Background Induction of broad immune responses at mucosal site remains a primary goal
for most vaccines against mucosal pathogens. Abundance of evidence indicates that the co …

Cyanovirin-N Inhibits Mannose-Dependent Mycobacterium–C-Type Lectin Interactions but Does Not Protect against Murine Tuberculosis

NN Driessen, HIM Boshoff, JJ Maaskant… - The Journal of …, 2012 - journals.aai.org
Abstract Cyanovirin-N (CV-N) is a mannose-binding lectin that inhibits HIV-1 infection by
blocking mannose-dependent target cell entry via C-type lectins. Like HIV-1, Mycobacterium …

GalNAc-specific soybean lectin inhibits HIV infection of macrophages through induction of antiviral factors

R Zhou, X Wang, H Liu, L Guo, Q Su, H Wang… - Journal of …, 2018 - Am Soc Microbiol
Although it has been shown that some mannose-binding lectins (MBLs) exhibit significant
activity against HIV infection, little is known about whether N-acetylgalactosamine (GalNAc) …

Chimeric Cyanovirin-MPER recombinantly engineered proteins cause cell-free virolysis of HIV-1

M Contarino, AR Bastian… - Antimicrobial agents …, 2013 - Am Soc Microbiol
Human immunodeficiency virus (HIV) is the primary etiologic agent responsible for the AIDS
pandemic. In this work, we used a chimeric recombinant protein strategy to test the …

Restriction of influenza A virus by SERINC5

KK Lai, JB Munro, G Shi, S Majdoul, AA Compton… - Mbio, 2022 - Am Soc Microbiol
ABSTRACT Serine incorporator 5 (Ser5), a transmembrane protein, has recently been
identified as a host antiviral factor against human immunodeficiency virus (HIV)-1 and …

Human Mannose Receptor 1 Attenuates HIV-1 Infectivity in a Virus Isolate-Specific Manner

H Saito, S Sukegawa, S Kao, K Strebel - Viruses, 2023 - mdpi.com
Human mannose receptor 1 (hMRC1) is a transmembrane glycoprotein that belongs to the
C-type lectin family and is expressed on the surface of most tissue macrophages. hMRC1 …